.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A systematic review and meta-analysis evaluated allergen immunotherapy for asthma, bringing together evidence on clinical outcomes and treatment effects across different forms of immunotherapy. The overall evidence suggested potential benefit for selected patients, particularly when allergic sensitization is clearly demonstrated and treatment is delivered in an appropriate clinical context. The paper is useful because it also highlights the limits of a one-size-fits-all approach. Immunotherapy is not simply another add-on for uncontrolled asthma; candidacy depends on the patient’s allergic phenotype, disease stability, relevant allergen exposure, and the balance of expected benefit and treatment burden. For HCPs, the practical workflow is to confirm clinically relevant sensitization, optimize standard asthma therapy, address adherence and inhaler technique, and then consider immunotherapy in patients who fit established criteria. This evidence aligns with the conference workshop on allergy and immunotherapy and with its broader focus on asthma phenotyping in everyday practice. The key message is therefore one of precision and selection: immunotherapy can be valuable for the right patient, but the quality of the phenotype and the clinical indication matter as much as the intervention itself.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A systematic review and meta-analysis evaluated allergen immunotherapy for asthma, bringing together evidence on clinical outcomes and treatment effects across different forms of immunotherapy. The overall evidence suggested potential benefit for selected patients, particularly when allergic sensitization is clearly demonstrated and treatment is delivered in an appropriate clinical context. The paper is useful because it also highlights the limits of a one-size-fits-all approach. Immunotherapy is not simply another add-on for uncontrolled asthma; candidacy depends on the patient’s allergic phenotype, disease stability, relevant allergen exposure, and the balance of expected benefit and treatment burden. For HCPs, the practical workflow is to confirm clinically relevant sensitization, optimize standard asthma therapy, address adherence and inhaler technique, and then consider immunotherapy in patients who fit established criteria. This evidence aligns with the conference workshop on allergy and immunotherapy and with its broader focus on asthma phenotyping in everyday practice. The key message is therefore one of precision and selection: immunotherapy can be valuable for the right patient, but the quality of the phenotype and the clinical indication matter as much as the intervention itself.
4 weeks back
A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
3 days back
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
4 weeks back
Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
4 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
4 days back
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
5 days back
